Prostate Cancer Trial, Recruiting NCT06559059 Sponsor: NYU Langone Health Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06559059
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People who are Veterans
  • People who are 18 years of age or older
  • People who have been newly diagnosed with lung, prostate, breast, or colon cancer within the past 3 months of a telemedicine visit
  • People who have attended an oncology (cancer care) appointment at a Veterans Affairs Medical Center (VAMC) during the study period

For healthcare providers and staff:

  • Doctors, nurse practitioners, physician assistants, or nurses who work at one of the participating Veterans Affairs Medical Centers
  • Providers or staff members who have helped care for at least 5 Veterans with cancer in the past 6 months at a VAMC location

Who may not be able to join:

For patients:

  • Veterans who have not seen any VA healthcare providers in the past year
  • People who were diagnosed with lung, prostate, breast, or colon cancer before this study
  • People who are currently pregnant

For healthcare providers and staff:

  • Providers or staff members who do not help treat Veterans with the specified cancers in oncology at a VA facility

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Danil Makarov, MD, MHS, NYU Langone Health

Phone: 646-501-3588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 June 2024
Est. completion
31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of raw telehealth visits; Fraction of patients engaging in at least one telehealth visit

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov